Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers
Completed · Phase 3 · Has a placebo group
Conditions studied: Hereditary Periodic Fevers
In brief
This study is to determine whether canakinumab is able to induce and maintain a clinically meaningful reduction of disease activity in participants with Hereditary Periodic Fevers (HPF) compared to placebo.
Key facts
- Study ID
- NCT02059291
- Run by
- Novartis Pharmaceuticals
- People needed
- 203
- Starts
- 2014-06-27
- Expected to finish
- 2017-07-04
- Last updated by the study team
- 2018-05-17
Who can join
Age: 0 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Ann Arbor, Michigan, United States
- Novartis Investigative Site — Cleveland, Ohio, United States
- Novartis Investigative Site — Edegem, Antwerpen, Belgium
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Hasselt, Belgium
- Novartis Investigative Site — Leuven, Belgium
- Novartis Investigative Site — Liège, Belgium
- Novartis Investigative Site — Calgary, Alberta, Canada
- Novartis Investigative Site — Vancouver, British Columbia, Canada
- Novartis Investigative Site — Bron, France
- Novartis Investigative Site — Le Kremlin-Bicêtre, France
- Novartis Investigative Site — Nîmes, France
- Novartis Investigative Site — Paris, France
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Essen, Germany
- Novartis Investigative Site — Germering, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — München, Germany
- Novartis Investigative Site — Saint Augustin, Germany
- Novartis Investigative Site — Tübingen, Germany
- Novartis Investigative Site — Budapest, Hungary
- Novartis Investigative Site — Budapest, Hungary
- Novartis Investigative Site — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.